Literature DB >> 22188929

The eradication of smallpox--an overview of the past, present, and future.

Donald A Henderson1.   

Abstract

The 30th anniversary of the declaration of smallpox eradication is a propitious time to look back on the evolutionary history of the program, its execution, and its legacy for the future. The eradication of history's most feared disease culminated a decade-long World Health Organization campaign which began despite skepticism and doubt and succeeded despite a never ending array of obstacles occasioned by floods, civil war, famine, and bureaucratic inertia. New concepts in public health management, surveillance, and the application of large-scale programs for vaccination were fostered and matured. A new generation of young health workers emerged who applied new approaches and experienced the gratification of public health achievement. A definitive legacy for the future was the extension of the program into an "Expanded Program on Immunization", now functioning world-wide and resulting in dramatic improvements in health through control of vaccine-preventable diseases. No less important are the growing number of multi-national programs whose foundations rest on the development of active case surveillance to measure achievement and to guide progress - poliomyelitis, measles, guinea worm, and rubella.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22188929     DOI: 10.1016/j.vaccine.2011.06.080

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  43 in total

Review 1.  Public trust and vaccine acceptance--international perspectives.

Authors:  Sachiko Ozawa; Meghan L Stack
Journal:  Hum Vaccin Immunother       Date:  2013-06-03       Impact factor: 3.452

2.  Structure-function characterization of three human antibodies targeting the vaccinia virus adhesion molecule D8.

Authors:  Michael H Matho; Andrew Schlossman; Iuliia M Gilchuk; Greg Miller; Zbigniew Mikulski; Matthias Hupfer; Jing Wang; Aruna Bitra; Xiangzhi Meng; Yan Xiang; Tom Kaever; Tzanko Doukov; Klaus Ley; Shane Crotty; Bjoern Peters; Linda C Hsieh-Wilson; James E Crowe; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2017-11-09       Impact factor: 5.157

Review 3.  Challenges for nationwide vaccine delivery in African countries.

Authors:  Mario Songane
Journal:  Int J Health Econ Manag       Date:  2017-10-19

4.  Parental Approach to the Prevention and Management of Fever and Pain Following Childhood Immunizations: A Survey Study.

Authors:  Ezzeldin Saleh; Geeta K Swamy; M Anthony Moody; Emmanuel B Walter
Journal:  Clin Pediatr (Phila)       Date:  2016-10-23       Impact factor: 1.168

5.  A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques.

Authors:  Jessica C Joyce; Timothy D Carroll; Marcus L Collins; Min-Hsin Chen; Linda Fritts; Joseph C Dutra; Tracy L Rourke; James L Goodson; Michael B McChesney; Mark R Prausnitz; Paul A Rota
Journal:  J Infect Dis       Date:  2018-06-05       Impact factor: 5.226

6.  Potent neutralization of vaccinia virus by divergent murine antibodies targeting a common site of vulnerability in L1 protein.

Authors:  Thomas Kaever; Xiangzhi Meng; Michael H Matho; Andrew Schlossman; Sheng Li; Inbal Sela-Culang; Yanay Ofran; Mark Buller; Ryan W Crump; Scott Parker; April Frazier; Shane Crotty; Dirk M Zajonc; Bjoern Peters; Yan Xiang
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

7.  Decision-making for foot-and-mouth disease control: Objectives matter.

Authors:  William J M Probert; Katriona Shea; Christopher J Fonnesbeck; Michael C Runge; Tim E Carpenter; Salome Dürr; M Graeme Garner; Neil Harvey; Mark A Stevenson; Colleen T Webb; Marleen Werkman; Michael J Tildesley; Matthew J Ferrari
Journal:  Epidemics       Date:  2015-12-10       Impact factor: 4.396

8.  Linear Epitopes in Vaccinia Virus A27 Are Targets of Protective Antibodies Induced by Vaccination against Smallpox.

Authors:  Thomas Kaever; Michael H Matho; Xiangzhi Meng; Lindsay Crickard; Andrew Schlossman; Yan Xiang; Shane Crotty; Bjoern Peters; Dirk M Zajonc
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

9.  Accelerating measles and rubella elimination through research and innovation - Findings from the Measles & Rubella Initiative research prioritization process, 2016.

Authors:  Gavin B Grant; Balcha G Masresha; William J Moss; Mick N Mulders; Paul A Rota; Saad B Omer; Abigail Shefer; Jennifer L Kriss; Matt Hanson; David N Durrheim; Robert Linkins; James L Goodson
Journal:  Vaccine       Date:  2019-03-20       Impact factor: 3.641

Review 10.  Nanodelivery of STING agonists against cancer and infectious diseases.

Authors:  Jiarong Zhou; Christian J Ventura; Ronnie H Fang; Liangfang Zhang
Journal:  Mol Aspects Med       Date:  2021-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.